Bryn Mawr Capital Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.01M Sell
9,249
-349
-4% -$106K 0.17% 116
2026
Q1
$2.05M Buy
9,598
+968
+11% +$216K 0.1% 143
2025
Q4
$1.48M Sell
8,630
-174
-2% -$27.1K 0.07% 176
2025
Q3
$1.18M Buy
8,804
+643
+8% +$68.1K 0.06% 194
2025
Q2
$794K Sell
8,161
-3,223
-28% -$256K 0.04% 225
2025
Q1
$828K Sell
11,384
-1,963
-15% -$155K 0.05% 209
2024
Q4
$964K Sell
13,347
-593
-4% -$45K 0.05% 224
2024
Q3
$1.14M Sell
13,940
-650
-4% -$56.5K 0.06% 202
2024
Q2
$1.55M Sell
14,590
-290
-2% -$27.8K 0.09% 173
2024
Q1
$1.45M Sell
14,880
-950
-6% -$83.6K 0.08% 183
2023
Q4
$1.24M Sell
15,830
-1,040
-6% -$70.9K 0.08% 194
2023
Q3
$1.06M Sell
16,870
-680
-4% -$44.7K 0.07% 203
2023
Q2
$1.13M Sell
17,550
-3,300
-16% -$186K 0.11% 156
2023
Q1
$1.11M Buy
20,850
+4,230
+25% +$208K 0.12% 150
2022
Q4
$699K Buy
+16,620
New +$695K 0.08% 183
2022
Q2
Sell
-4,360
Closed -$234K 158
2022
Q1
$234K Buy
+4,360
New +$254K 0.07% 148

Other funds holding LRCX

Bryn Mawr Capital Management's LRCX Position: Q2 2026 in Review

Bryn Mawr Capital Management reduced its Lam Research (LRCX) stake by 3.6% in Q2 2026, selling an estimated $106K and leaving 9,249 shares worth $4.01M. The position accounts for 0.17% of the portfolio, ranked #116.

Bryn Mawr Capital Management first reported a position in LRCX in Q1 2022 and has held it in 16 quarters since. 3,121 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Bryn Mawr Capital Management held 9,249 shares of Lam Research worth $4.01M as of Q2 2026.
  • Bryn Mawr Capital Management sold 349 Lam Research shares in Q2 2026, an estimated $106K.
  • Lam Research made up 0.17% of Bryn Mawr Capital Management's portfolio in Q2 2026, its #116 holding.
  • Bryn Mawr Capital Management first reported a position in Lam Research in Q1 2022 and has held it in 16 quarters since.
  • 3,121 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.